Skip to main content
Midas Edge

DarioHealth Corp

For the period ended Dec 31, 2023. Filed Mar 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 28, 2024

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Statements of Changes in Stockholders’ Equity

​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Preferred Stock · ​ · paid-in · ​ · Accumulated · ​ · stockholders’
​ · Number · ​ · Amount · ​ · Number · ​ · Amount · ​ · capital · ​ · deficit · ​ · equity
Balance as of January 1, 202216,573,420​$2​11,927​$*) -​$307,561​$(222,014)​$85,549
​​​​​​​​​​​​​​​​​​​​
Exercise of warrants81,221​​*) -​—​​—​​—​​—​​—
Issuance of common stock to consultants and service provider62,926​​*) -​—​​—​​377​​—​​377
Issuance of common stock to directors and employees29,755​​*) -​—​​—​​190​​—​​190
Deemed dividend related to issuance of Preferred Stock—​​—​—​​—​​1,643​​(1,643)​​—
Conversion of preferred stock to common stock2,778,450​​*) -​(8,360)​​*) -​​—​​—​​*) -
Issuance of warrants to service providers​—​​—​—​​—​​3,105​​—​​3,105
Issuance of common stock, net of issuance cost​4,747,761​​1​—​​—​​38,287​​—​​38,288
Issuance of Common Stock, net of issuance cost upon Acquisitions​378,492​​*) -​—​​—​​1,186​​—​​1,186
Earnout resolution​—​​​​​​​​​​328​​​​​328
Repurchase and retirement of common stock​(58,657)​​​​​​​​​​(134)​​​​​(134)
Stock-based compensation1,131,102​​—​—​​—​​13,303​​—​​13,303
Net loss—​​—​—​​—​​—​​(62,193)​​(62,193)
Balance as of December 31, 202225,724,470​$3​3,567​$*) -​$365,846​$(285,850)​$79,999
​​​​​​​​​​​​​​​​​​​​
Exercise of Options​4,800​​*) -​—​​—​​—​​—​​—
Exercise of warrants​86,983​​*) -​—​​—​​—​​—​​—
Extinguishment of preferred stock in connection with preferred stock modification​—​​​​—​​​​​984​​(984)​​​
Deemed dividend related to Preferred Stock—​​—​—​​—​​3,100​​(3,100)​​—
Conversion of preferred stock to common stock3,582​​*) -​(10)​​*) -​​—​​—​​*) -
Issuance of warrants to service providers​—​​—​—​​—​​3,516​​—​​3,516
Issuance of common and preferred stock, net of issuance cost​408,043​​—​15,402​​—​​16,482​​—​​16,482
Issuance of warrants related to loan agreement, net of issuance cost​—​​—​—​​—​​1,389​​—​​1,389
Common stock related to earnout consideration​76,637​​*) -​—​​—​​—​​—​​—
Stock-based compensation887,334​​*) -​—​​—​​16,185​​—​​16,185
Net loss—​​—​—​​—​​—​​(59,427)​​(59,427)
Balance as of December 31, 202327,191,849​$3​18,959​$*) -​$407,502​$(349,361)​$58,144

*) Represents an amount lower than $1.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.